vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and National Storage Affiliates Trust (NSA). Click either name above to swap in a different company.
Axsome Therapeutics, Inc. is the larger business by last-quarter revenue ($196.0M vs $187.0M, roughly 1.0× National Storage Affiliates Trust). National Storage Affiliates Trust runs the higher net margin — 12.2% vs -14.6%, a 26.8% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs -1.6%). National Storage Affiliates Trust produced more free cash flow last quarter ($299.8M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs -2.4%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
National Storage Affiliates Trust is a U.S.-headquartered real estate investment trust focused on self-storage assets. It owns, operates and acquires self-storage facilities across dozens of U.S. states, offering secure storage solutions for residential and commercial customers.
AXSM vs NSA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $187.0M |
| Net Profit | $-28.6M | $22.9M |
| Gross Margin | — | 72.5% |
| Operating Margin | -13.8% | 20.2% |
| Net Margin | -14.6% | 12.2% |
| Revenue YoY | 65.0% | -1.6% |
| Net Profit YoY | 61.9% | 36.8% |
| EPS (diluted) | $-0.55 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $187.0M | ||
| Q3 25 | $171.0M | $188.7M | ||
| Q2 25 | $150.0M | $188.8M | ||
| Q1 25 | $121.5M | $188.4M | ||
| Q4 24 | $118.8M | $190.1M | ||
| Q3 24 | $104.8M | $193.6M | ||
| Q2 24 | $87.2M | $190.4M | ||
| Q1 24 | $75.0M | $196.1M |
| Q4 25 | $-28.6M | $22.9M | ||
| Q3 25 | $-47.2M | $18.4M | ||
| Q2 25 | $-48.0M | $19.5M | ||
| Q1 25 | $-59.4M | $13.0M | ||
| Q4 24 | $-74.9M | $16.7M | ||
| Q3 24 | $-64.6M | $18.7M | ||
| Q2 24 | $-79.3M | $17.1M | ||
| Q1 24 | $-68.4M | $59.0M |
| Q4 25 | — | 72.5% | ||
| Q3 25 | — | 70.7% | ||
| Q2 25 | — | 70.5% | ||
| Q1 25 | — | 70.7% | ||
| Q4 24 | — | 72.5% | ||
| Q3 24 | — | 72.8% | ||
| Q2 24 | — | 72.6% | ||
| Q1 24 | — | 72.1% |
| Q4 25 | -13.8% | 20.2% | ||
| Q3 25 | -27.0% | 15.8% | ||
| Q2 25 | -24.5% | 16.5% | ||
| Q1 25 | -46.9% | 11.0% | ||
| Q4 24 | -61.1% | 14.5% | ||
| Q3 24 | -59.8% | 15.8% | ||
| Q2 24 | -89.5% | 17.2% | ||
| Q1 24 | -89.7% | 48.9% |
| Q4 25 | -14.6% | 12.2% | ||
| Q3 25 | -27.6% | 9.8% | ||
| Q2 25 | -32.0% | 10.3% | ||
| Q1 25 | -48.9% | 6.9% | ||
| Q4 24 | -63.1% | 8.8% | ||
| Q3 24 | -61.7% | 9.7% | ||
| Q2 24 | -91.0% | 9.0% | ||
| Q1 24 | -91.1% | 30.1% |
| Q4 25 | $-0.55 | $0.23 | ||
| Q3 25 | $-0.94 | $0.17 | ||
| Q2 25 | $-0.97 | $0.19 | ||
| Q1 25 | $-1.22 | $0.10 | ||
| Q4 24 | $-1.54 | $0.19 | ||
| Q3 24 | $-1.34 | $0.18 | ||
| Q2 24 | $-1.67 | $0.16 | ||
| Q1 24 | $-1.44 | $0.65 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $23.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $88.3M | $946.0M |
| Total Assets | $689.8M | $5.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $23.3M | ||
| Q3 25 | $325.3M | $26.3M | ||
| Q2 25 | $303.0M | $26.1M | ||
| Q1 25 | $300.9M | $19.3M | ||
| Q4 24 | $315.4M | $50.4M | ||
| Q3 24 | $327.3M | $69.9M | ||
| Q2 24 | $315.7M | $59.0M | ||
| Q1 24 | $331.4M | $64.2M |
| Q4 25 | $88.3M | $946.0M | ||
| Q3 25 | $73.7M | $973.1M | ||
| Q2 25 | $73.1M | $1.0B | ||
| Q1 25 | $53.2M | $1.0B | ||
| Q4 24 | $57.0M | $1.1B | ||
| Q3 24 | $92.9M | $986.9M | ||
| Q2 24 | $102.9M | $1.2B | ||
| Q1 24 | $144.0M | $1.3B |
| Q4 25 | $689.8M | $5.1B | ||
| Q3 25 | $669.3M | $5.1B | ||
| Q2 25 | $639.8M | $5.2B | ||
| Q1 25 | $596.7M | $5.3B | ||
| Q4 24 | $568.5M | $5.4B | ||
| Q3 24 | $561.5M | $5.4B | ||
| Q2 24 | $548.2M | $5.3B | ||
| Q1 24 | $545.7M | $5.4B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $338.5M |
| Free Cash FlowOCF − Capex | $-18.7M | $299.8M |
| FCF MarginFCF / Revenue | -9.6% | 160.3% |
| Capex IntensityCapex / Revenue | 0.0% | 20.7% |
| Cash ConversionOCF / Net Profit | — | 14.79× |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $541.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $338.5M | ||
| Q3 25 | $1.0M | $100.2M | ||
| Q2 25 | $-32.4M | $79.9M | ||
| Q1 25 | $-43.4M | $85.6M | ||
| Q4 24 | $-26.2M | $363.1M | ||
| Q3 24 | $-18.6M | $105.7M | ||
| Q2 24 | $-30.1M | $83.2M | ||
| Q1 24 | $-53.5M | $94.0M |
| Q4 25 | $-18.7M | $299.8M | ||
| Q3 25 | $988.0K | $88.0M | ||
| Q2 25 | $-32.4M | $73.8M | ||
| Q1 25 | $-43.7M | $79.9M | ||
| Q4 24 | $-26.2M | $344.4M | ||
| Q3 24 | $-18.7M | $101.8M | ||
| Q2 24 | $-30.2M | $79.5M | ||
| Q1 24 | $-53.6M | $88.6M |
| Q4 25 | -9.6% | 160.3% | ||
| Q3 25 | 0.6% | 46.6% | ||
| Q2 25 | -21.6% | 39.1% | ||
| Q1 25 | -36.0% | 42.4% | ||
| Q4 24 | -22.1% | 181.2% | ||
| Q3 24 | -17.9% | 52.6% | ||
| Q2 24 | -34.6% | 41.7% | ||
| Q1 24 | -71.4% | 45.2% |
| Q4 25 | 0.0% | 20.7% | ||
| Q3 25 | 0.0% | 6.5% | ||
| Q2 25 | 0.0% | 3.2% | ||
| Q1 25 | 0.3% | 3.0% | ||
| Q4 24 | 0.0% | 9.8% | ||
| Q3 24 | 0.1% | 2.0% | ||
| Q2 24 | 0.1% | 1.9% | ||
| Q1 24 | 0.1% | 2.7% |
| Q4 25 | — | 14.79× | ||
| Q3 25 | — | 5.44× | ||
| Q2 25 | — | 4.10× | ||
| Q1 25 | — | 6.59× | ||
| Q4 24 | — | 21.70× | ||
| Q3 24 | — | 5.65× | ||
| Q2 24 | — | 4.88× | ||
| Q1 24 | — | 1.59× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
